Stay updated on Safety Tolerability in IPF Clinical Trial
Sign up to get notified when there's something new on the Safety Tolerability in IPF Clinical Trial page.

Latest updates to the Safety Tolerability in IPF Clinical Trial page
- Check3 days agoChange DetectedA site-wide banner announces a transition in NIH terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check10 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2, while the page continues to display a 403 error.SummaryDifference0.2%

- Check17 days agoChange DetectedThe displayed ClinicalTrials.gov site revision changes from v3.7.0 to v3.7.1 on the error page.SummaryDifference0.2%

- Check38 days agoChange DetectedA 403 Forbidden error page is displayed for the study entry, replacing the normal study record content. This indicates restricted access to the page.SummaryDifference19%

- Check59 days agoChange DetectedThe page revision label updated from v3.6.5 to v3.6.6, indicating a new build of the Study Details page. It does not alter study content, eligibility criteria, or results.SummaryDifference0.1%

- Check73 days agoChange DetectedThe page now displays the full study record for NCT02503657 (MN-001-IPF-201), including the overview, design, eligibility criteria, outcomes, enrollment details, and locations. This brings the complete IPF trial information back online for users seeking study specifics.SummaryDifference52%

Stay in the know with updates to Safety Tolerability in IPF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Tolerability in IPF Clinical Trial page.